The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.494
https://www.valueinhealthjournal.com/article/S1098-3015(16)31861-7/fulltext
Title :
The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31861-7&doi=10.1016/j.jval.2016.09.494
First page :
A432
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
469